Sublobar Resection for Early-Stage Lung Cancer: An Oncologically Valid Procedure?

Area of Science:

• Thoracic surgery
• Surgical oncology
• Minimally invasive procedures

Background:

• Sublobar resection, encompassing anatomical segmentectomy and wide wedge excision, is increasingly utilized in minimally invasive thoracic surgery.
• The precise role and oncological safety of sublobar resections compared to lobectomy remain subjects of ongoing debate and investigation.

Discussion:

• The controversy surrounding sublobar resection stems from concerns regarding local recurrence and long-term survival, particularly in the context of non-small cell lung cancer.
• Balancing the benefits of lung parenchyma preservation with oncological principles is crucial when selecting between sublobar resection and lobectomy.

Key Insights:

• Current evidence suggests that carefully selected patients may benefit from sublobar resection, achieving comparable survival rates to lobectomy for early-stage lung cancers.
• Technological advancements and improved understanding of tumor biology are refining patient selection criteria and surgical techniques for sublobar resections.

Outlook:

• Future research should focus on prospective, multi-center trials to establish definitive guidelines for sublobar resection in various lung cancer scenarios.
• Standardization of surgical techniques and long-term follow-up are essential to fully elucidate the oncological outcomes and functional benefits of sublobar resection.